Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Tumor Characteristics, Pre-transplant Treatments and Immunosuppression on Survival After Liver Transplantation for Hepatocellular Carcinoma - a European Registry Study

NCT02995096 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT02995096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02995096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Tumor Characteristics, Pre-transplant Treatments and Immunosuppression on Survival After Liver Transplantation for Hepatocellular Carcinoma - a European Registry Study
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Completed
Start date
January 31, 2016
Completion date
March 31, 2019
Enrollment
23,124 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation